Profound Medical Corp. (NASDAQ:PROF – Get Rating) – Analysts at Raymond James issued their FY2027 earnings per share (EPS) estimates for Profound Medical in a research note issued on Thursday, June 15th. Raymond James analyst R. Sarugaser forecasts that the company will post earnings of $2.87 per share for the year. Raymond James currently has […]
Profound Medical (NASDAQ:PROF – Get Rating) had its target price boosted by Raymond James from $17.00 to $20.00 in a report published on Monday morning, BayStreet.CA reports. They currently have a strong-buy rating on the stock. Separately, Jefferies Financial Group lowered shares of Profound Medical from a buy rating to a hold rating and boosted […]
Profound Medical (NASDAQ:PROF – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, May 10th. Analysts expect Profound Medical to post earnings of ($0.32) per share for the quarter. Profound Medical (NASDAQ:PROF – Get Rating) last released its quarterly earnings data on Tuesday, March 7th. The company […]
Jefferies Financial Group cut shares of Profound Medical (NASDAQ:PROF – Get Rating) from a buy rating to a hold rating in a report published on Tuesday, Marketbeat.com reports. The brokerage currently has $10.00 target price on the stock, up from their prior target price of $5.50. Jefferies Financial Group also issued estimates for Profound Medical’s […]
Equities research analysts predict that Profound Medical Corp. (NASDAQ:PROF – Get Rating) will report $2.00 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Profound Medical’s earnings. Profound Medical reported sales of $2.63 million in the same quarter last year, which indicates a negative year […]